跳至主要内容
临床试验/ACTRN12609001041246
ACTRN12609001041246已完成4 期

In women receiving spinal anaesthesia for caesarean section, is there a difference in the opioid dose-sparing, analgesic efficacy and quality of post-operative pain relief provided by multimodal postoperative analgesic regimens based on patient controlled epidural analgesia (PCEA) with pethidine, together with either placebo, cyclo-oxygenase 2 enzyme (COX-2) inhibitors, paracetamol or COX-2 inhibitors and paracetamol in combination.

King Edward Memorial Hospital for Women0 个研究点目标入组 120 人开始时间: 2009年12月4日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Elective caesarean section under combined spinal epidural anaesthesia
  • American Society of Anesthesiologists classification 1 or 2

排除标准

  • Pre-operative use of opioid medication
  • Contraindication to combined spinal epidural anaesthesia
  • Contraindication to parecoxib, celecoxib, paracetamol or tramadol
  • Known intolerance or allergy to oxycodone, morphine, parecoxib, celecoxib or sulphonamides
  • Pre-operative pruritus or nausea
  • Failure to identify the subarachnoid space or to catheterise the epidural space at the time of combined spinal epidural anaesthesia
  • Inadvertent dural puncture with the epidural needle or catheter
  • Requirement for intra-operative opioid or epidural analgesics other than local anaesthetic
  • Conversion to general anaesthesia

研究者

发起方
King Edward Memorial Hospital for Women

相似试验